HSPA5 and breast cancer: In MDA-MB-231 and T-47 human breast cancer cells, EGCG is able to block the ATPase domain of BiP, suppressing its anti-apoptotic function, and sensitizes these cells to etoposide-induced caspase-7 activation and apoptosis [134].